AveX­is sci­en­tif­ic founder was axed — and No­var­tis names a new CSO in wake of an ethics scan­dal

Now at the cen­ter of a storm of con­tro­ver­sy over its de­ci­sion to keep its knowl­edge of ma­nip­u­lat­ed da­ta hid­den from reg­u­la­tors dur­ing an FDA re­view, No­var­tis CEO Vas Narasimhan has found a long­time vet­er­an in the ranks to head the sci­en­tif­ic work un­der­way at AveX­is, where the in­ci­dent oc­curred. And the sci­en­tif­ic founder has hit the ex­it.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER